The biopharmaceutical contract biomanufacturing market growing at a CAGR of 10.7%

By | September 27, 2021

Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs London Roots Analysis has announced the addition of the “Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030” report to its list of offerings. Given the rising popularity of biologics… Read More »

CAR-T therapies market is characterized by a healthy pipeline of promising therapies

By | September 27, 2021

Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute… Read More »

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030

By | September 27, 2021

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings. Although biopharmaceuticals offer significant profit margins and… Read More »

Oligonucleotide Synthesis, Modification and Purification Services Market

By | September 20, 2021

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030” The report features… Read More »

Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical and clinical research-related services to medical device-focused business entities, claims Roots Analysis

By | September 20, 2021

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers. To order this… Read More »